| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |